Neurological effectsof premenstrual dysphoric disorder
Keywords:
Premenstrual Dysphoric Disorder, neurological changes, female behavior, serotonin, management.Abstract
Premenstrual dysphoric disorder (PMDD) is a serious condition that affects a significant proportion of women of childbearing age, characterized by intense physical, emotional, and behavioral symptoms that occur during the luteal phase of the menstrual cycle. Associated neurological changes include alterations in serotonin and the central nervous system, which may contribute to the onset of irritability, anxiety, depression, and behavioral changes. The objective of this study is to present the neurological changes associated with premenstrual dysphoric disorder (PMDD). This research was conducted based on a literature review and a search for articles in three databases—PubMed, SCOPUS, and ClinicalKey— using inclusion and exclusion criteria and keywords related to the topic. Alterations in serotonin and the central nervous system and their relationship to intense physical, emotional, and behavioral symptoms significantly impact the quality of life of women of childbearing age. It is concluded that early identification of this disorder, together with appropriate management, including pharmacological and psychosocial therapies and treatment strategies, are crucial to mitigating its effects and improving patients' quality of life.Downloads
References
Takeda T. Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder. J Obstet Gynaecol Res. 2023 [citado 08/03/2025];49(2):510-518. Disponible en: https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.15484
Tiranini L, Nappi RE. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Fac Rev. 2022 [citado 08/03/2025];11:11. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9066446/
Haußmann J, Goeckenjan M, Haußmann R, Wimberger P. Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment. Nervenarzt. 2024 [citado 08/03/2025];95(3):268-274. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10914875 /
Alcocer Vergara LM, Charris Niebles MC, García Revollo JC, Lacouture Abuchaibe O, Meza González YA, Peñaloza Gutiérrez de Piñeres A. Prevalencia del Síndrome Premenstrual (SPM) y Trastorno Disfórico Premenstrual (TDPM) y su relación con factores sociodemográficos y antecedentes gineco-obstétricos en estudiantes de la Universidad del Norte con edad fértil entre los 18-25 años de edad en la ciudad de Barranquilla para el primer periodo del año 2015 [Tesis]. [Barranquilla, Colombia]: Universidad del Norte; 2015.89p. Disponible en: https://manglar.uninorte.edu.co/bitstream/handle/10584/10748/1018450112.pdf?sequence=1&isAllowed=y
Álvarez J.Trastorno Disfórico Premenstrual (TDPM): Identificación, Orígenes y Manejo Terapéutico. Madrid, España: Mentes Abiertas Psicología;22/04/2023 [citado 05/08/2024]. Disponible en: https://www.mentesabiertaspsicologia.com/blog-psicologia/trastorno-disforico-premenstrual-tdpm-identificacion-origenes-y-manejo-terapeutico
Mishra S, Elliott H, Marwaha R. Premenstrual Dysphoric Disorder. Treasure Island (FL): StatPearls; 2023 [citado 18/06/2024]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK532307/
Yonkers KA, Simoni MK. Premenstrual Dysphoric Disorder: Etiology, Diagnosis, and Treatment Update. Obstet Gynecol Clin North Am. 2023;50(1):89-105.
Dubol M, Epperson CN, Sacher J, Pletzer B, Derntl B, Gizewski ER, Lanzenberger R. Neuroactive Steroids and Affective Symptoms Across the Menstrual Cycle. J Clin Endocrinol Metab. 2021; 106(3):e1252-e1269.
Pearlstein T Steiner M. Premenstrual Dysphoric Disorder: Burden of Illness and Treatment Update. J Psychiatry Neurosci. 2008 [citado 08/09/2024];33(4):291-301. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC2440788/
Martínez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, et al. The Role of Allopregnanolone in Premenstrual Dysphoric Disorder. Biol Psychiatry. 2020;87(10):897-907.
Baller EB, Wei SM, Kohn PD, Rubinow DR, Alarcón G, Schmidt PJ, et al. Brain Structure and Function in Premenstrual Dysphoric Disorder: A Systematic Review. Arch Womens Ment Health. 2023;26(1):1-16.
Lustyk MK, Gerrish WG, Shaver S, Keys SL. Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2009 [citado 08/07/2024];12(2):85-96. Disponible en: https://link.springer.com/article/10.1007/s00737-009-0052-y
Ríos E. El Laberinto Hormonal: Un Estudio Profundo del TDPM. Medrid, España: Salud Femenina; 2023.
Morales L. TDPM: Más Allá de los Síntomas. Colombia: Ediciones Bienestar Emocional; 2022.
Beddig T, Reinhard I, Kuehner C. Estrés, estado de ánimo y cortisol durante la vida diaria en mujeres con trastorno disfórico premenstrual (TDPM). Psiconeuroendocrinología. 2019 [citado 15/07/2024];109:104372. Disponible en: https://www-sciencedirect-com.translate.goog/science/article/abs/pii/S0306453019302100?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
Kelderhouse K, Smith Taylor J. A Review of Treatment and Management Modalities for Premenstrual Dysphoric Disorder. NWH. 2013 [citado 08/07/2024];17(4):294-305. Disponible en: https://www.nwhjournal.org/article/S1751-4851(15)30776-5/abstract
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sylvia del Pilar Núñez Arroba, Allison Stephanie Mayorga Gutiérrez, Germán Alfredo Vargas Cedeño, Dayana Desiree Zabala Duque
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ACCESS AND DISTRIBUTION POLICY
All published articles are open access contributions, which are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided that the primary source of publication is properly cited.
